This Programme is targeted at companies who are considering an investment in innovation and want their team to embrace the BioInnovate process for innovating health technologies. During BioInnovate 101: Essentials of Health Technology Innovation, you'll work in dynamic, multidisciplinary teams—including clinical, engineering, regulatory, and quality professionals—to tackle real-world healthcare challenges and turn ideas into impactful innovations.
Content includes
Affiliated with Stanford University’s globally renowned BioDesign program, BioInnovate Ireland has a proven track record in training and supporting the next generation of global entrepreneurs, Medtech experts and healthcare leaders.
On completion of this Programme the learner will/should be able to:
- Demonstrate awareness of the process for innovating medical technologies.
- Demonstrate awareness of how to identify an important unmet medical need taking into consideration clinical, scientific and market knowledge.
- Appreciate the holistic view of the BioInnovate process including a broad understanding of the considerations and stakeholders involved in bringing a new innovation from a healthcare problem to a commercial solution.
- Demonstrate effectiveness in presenting the unique problem to be solved.
- Demonstrate effectiveness in developing filtering criteria for clinical needs.
- Communicate the value proposition of a concept.
Accommodation for BioInnovate 101 Course Attendees
The Galmont Hotel is offering a corporate rate of €190 per night for BioInnovate course attendees who book using their company email. Attendees are also encouraged to check the hotel's website, as a better rate may be available. For more details or to book your stay, please contact The Galmont Hotel directly.
Who should attend
This Programme is suitable for a broad range of disciplines including, R&D Engineers, Software Engineers and Data Scientists; Quality and Regulatory affairs professionals; Marketing and Post-market surveillance professionals; Healthcare Professionals and beyond.